The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
Int J Infect Dis
; 111: 196-203, 2021 Oct.
Article
em En
| MEDLINE
| ID: mdl-34455081
ABSTRACT
OBJECTIVES:
Streptococcus pneumoniae is the leading bacterial pathogen causing respiratory infections. Since the COVID-19 pandemic emerged, less invasive pneumococcal disease (IPD) was identified by surveillance systems worldwide. Measures to prevent transmission of SARS-CoV-2 also reduce transmission of pneumococci, but this would gradually lead to lower disease rates.DESIGN:
Here, we explore additional factors contributing to the instant drop in pneumococcal disease cases captured in surveillance.RESULTS:
Our observations on referral practices and other impediments to diagnostic testing indicate that residual IPD has likely occurred but remained undetected by conventional hospital-based surveillance.CONCLUSIONS:
Depending on the setting, we discuss alternative monitoring strategies that could improve understanding of pneumococcal disease dynamics.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Infecções Pneumocócicas
/
COVID-19
Tipo de estudo:
Incidence_studies
/
Prognostic_studies
Limite:
Adult
/
Humans
/
Infant
País como assunto:
Europa
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article